OK Brentie & opc,

I apologize, I got that wrong. I looked up the old NDAs this morning, and they were going for T1 and T2.

So I'll just throw that model right out the window. That's OK, I just recently crunched that one based on the past run-up in share price prior to the last PDUFA. Still with an indication for use in early T2, I still think we could see a run to $10 prior to approval, based on 280 M shares outstanding.

But I'll just stick to some of my other models based on incidence and prevalence of diabetes in this country and worldwide for my long-term outlook - ala OOG's models.

Thanks for keeping me straight!